Cargando…
SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma
Since the SOX2 amplification was identified in lung squamous cell carcinoma (lung SCC), SOX2 transcriptional downstream targets have been actively investigated; however, such targets are often cell line specific. Here, in order to identify highly consensus SOX2 downstream genes in lung SCC cells, we...
Autores principales: | Fukazawa, Takuya, Guo, Minzhe, Ishida, Naomasa, Yamatsuji, Tomoki, Takaoka, Munenori, Yokota, Etsuko, Haisa, Minoru, Miyake, Noriko, Ikeda, Tomoko, Okui, Tatsuo, Takigawa, Nagio, Maeda, Yutaka, Naomoto, Yoshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742851/ https://www.ncbi.nlm.nih.gov/pubmed/26846300 http://dx.doi.org/10.1038/srep20113 |
Ejemplares similares
-
Targeted silencing of SOX2 by an artificial transcription factor showed antitumor effect in lung and esophageal squamous cell carcinoma
por: Yokota, Etsuko, et al.
Publicado: (2017) -
Clinical application of a lung cancer organoid (tumoroid) culture system
por: Yokota, Etsuko, et al.
Publicado: (2021) -
False-Positive Cases of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomographic Scans in Metastasis of Esophageal Cancer
por: Yamatsuji, Tomoki, et al.
Publicado: (2017) -
Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma
por: Yoshida, Masakazu, et al.
Publicado: (2018) -
Suppression of Tumor Growth and Downregulation of Platelet‐derived Endothelial Cell Growth Factor/Thymidine Phosphorylase in Tumor Cells by Angiogenesis Inhibitor TNP‐470
por: Mori, Jun, et al.
Publicado: (2000)